Fangzheng, W., Chuner, J., Quanquan, S., Zhimin, Y., Tongxin, L., Jiping, L., . . . Yangming, J. (2017). Addition of 5-fluorouracil to docetaxel/cisplatin does not improve survival in locoregionally advanced nasopharyngeal carcinoma. Oncotarget.
Citación estilo ChicagoFangzheng, Wang, et al. "Addition of 5-fluorouracil to Docetaxel/cisplatin Does Not Improve Survival in Locoregionally Advanced Nasopharyngeal Carcinoma." Oncotarget 2017.
Cita MLAFangzheng, Wang, et al. "Addition of 5-fluorouracil to Docetaxel/cisplatin Does Not Improve Survival in Locoregionally Advanced Nasopharyngeal Carcinoma." Oncotarget 2017.
Precaución: Estas citas no son 100% exactas.